Piperacillin/tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing.
Loading...
Issue Date
12/17/2024
Authors
Lodise, Thomas P
Bhavnani, Sujata M
Ambrose, Paul G
Sader, Helio S
Andes, David R
Pogue, Jason M
Degree
Advisor
Committee Members
Journal Title
Journal ISSN
Volume Title
Abstract
The in vitro susceptibility testing interpretive criteria (STIC) for TZP against Enterobacterales were recently updated by the Food and Drug Administration (FDA), Clinical & Laboratory Standards Institute (CLSI), and European Committee on Antimicrobial Susceptibility Testing (EUCAST). The United States Committee on Antimicrobial Susceptibility Testing (USCAST) also recently reviewed TZP STIC for Enterobacterales and arrived at different STIC for Enterobacterales and herein we explain our recommendations and rationale behind them. Based on our review of the available data, USCAST does not recommend TZP STIC for certain Enterobacterales species that have a moderate to high likelihood of clinically significant AmpC production (E. cloacae, C. freundii, and K. aerogenes only) or for third-generation cephalosporin-non-susceptible (3GC-NS) Enterobacterales. USCAST recommends a TZP susceptibility breakpoint of ≤ 16/4 mg/L for third-generation cephalosporin-susceptible (3GC-S) Enterobacterales but only endorses the use of extended infusion TZP regimens for patients with infections due to these pathogens.
Citation
Lodise TP, Bhavnani SM, Ambrose PG, Sader HS, Andes D, Pogue JM. Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing. Clin Infect Dis. 2024 Dec 17;79(6):1354-1362. doi: 10.1093/cid/ciae328. PMID: 38902929; PMCID: PMC11650869.
ACPHS Research Commons URI
Description
Click on the Resource Link to access the article (may not be free).